← Evidence map

ArticleReumatologia2021

Febuxostat versus allopurinol for patients with gout: is it time to overcome concerns regarding cardiovascular safety?

Dimitrios Ioannis Patoulias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 35079188